Skip to main content

We've updated our Privacy Policy. Questions? Email us any time at privacy@ground.news

SubscribeLogin
Published • loading... • Updated

Uniquity Bio Adds Regulatory Chief Before Phase II Readouts

Summary by MyChesCo
MALVERN, PA — Uniquity Bio appointed Jason Moore as senior vice president of regulatory and quality as the Blackstone-backed drug developer prepares for Phase II results that could determine whether …
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

MyChesCoMyChesCo

Uniquity Bio Adds Regulatory Chief Before Phase II Readouts

MALVERN, PA — Uniquity Bio appointed Jason Moore as senior vice president of regulatory and quality as the Blackstone-backed drug developer prepares for Phase II results that could determine whether …

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MyChesCo broke the news on Saturday, August 8, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Malvern, Pennsylvania icon

Malvern, Pennsylvania

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal